Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Ajellomyces capsulata U1 small nuclear ribonucleoprotein C (HCBG_04212) CSB-YP022331AYZ
CSB-EP022331AYZ
CSB-BP022331AYZ
CSB-MP022331AYZ
CSB-EP022331AYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Nicotinate phosphoribosyltransferase (pncB) CSB-YP015451SWU
CSB-EP015451SWU
CSB-BP015451SWU
CSB-MP015451SWU
CSB-EP015451SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Glycine cleavage system H protein (gcvH) CSB-YP009335SWU
CSB-EP009335SWU
CSB-BP009335SWU
CSB-MP009335SWU
CSB-EP009335SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Agmatinase (speB) CSB-YP001447SWU
CSB-EP001447SWU
CSB-BP001447SWU
CSB-MP001447SWU
CSB-EP001447SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C GTPase Era (era) CSB-YP007759SWU
CSB-EP007759SWU
CSB-BP007759SWU
CSB-MP007759SWU
CSB-EP007759SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Methionyl-tRNA formyltransferase (fmt) CSB-YP015150SWU
CSB-EP015150SWU
CSB-BP015150SWU
CSB-MP015150SWU
CSB-EP015150SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Xaa-Pro dipeptidase (pepQ) CSB-YP017784SWU
CSB-EP017784SWU
CSB-BP017784SWU
CSB-MP017784SWU
CSB-EP017784SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfobacterium autotrophicum Thymidylate kinase (tmk) CSB-YP007226DJK
CSB-EP007226DJK
CSB-BP007226DJK
CSB-MP007226DJK
CSB-EP007226DJK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina Succinyl-CoA ligase [ADP-forming] subunit beta (sucC) CSB-YP022917EUA
CSB-EP022917EUA
CSB-BP022917EUA
CSB-MP022917EUA
CSB-EP022917EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina Nucleoside diphosphate kinase (ndk) CSB-YP015889EUA
CSB-EP015889EUA
CSB-BP015889EUA
CSB-MP015889EUA
CSB-EP015889EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina ATP synthase subunit delta (atpH) CSB-YP002355EUA
CSB-EP002355EUA
CSB-BP002355EUA
CSB-MP002355EUA
CSB-EP002355EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina Methylthioribose-1-phosphate isomerase (mtnA) CSB-YP014799EUA
CSB-EP014799EUA
CSB-BP014799EUA
CSB-MP014799EUA
CSB-EP014799EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brachyspira hyodysenteriae ATP synthase subunit alpha (atpA) CSB-YP002344BVT
CSB-EP002344BVT
CSB-BP002344BVT
CSB-MP002344BVT
CSB-EP002344BVT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brachyspira hyodysenteriae GMP synthase [glutamine-hydrolyzing] (guaA), partial CSB-YP009582BVT
CSB-EP009582BVT
CSB-BP009582BVT
CSB-MP009582BVT
CSB-EP009582BVT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Wolbachia sp. subsp. Drosophila simulans ATP synthase subunit alpha (atpA), partial CSB-YP002344WBP
CSB-EP002344WBP
CSB-BP002344WBP
CSB-MP002344WBP
CSB-EP002344WBP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Wolbachia sp. subsp. Drosophila simulans Malate dehydrogenase (mdh) CSB-YP013623WBP
CSB-EP013623WBP
CSB-BP013623WBP
CSB-MP013623WBP
CSB-EP013623WBP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Wolbachia sp. subsp. Drosophila simulans Elongation factor G (fusA), partial CSB-YP009373WBP
CSB-EP009373WBP
CSB-BP009373WBP
CSB-MP009373WBP
CSB-EP009373WBP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Wolbachia sp. subsp. Drosophila simulans Peptide deformylase (def) CSB-YP017707WBP
CSB-EP017707WBP
CSB-BP017707WBP
CSB-MP017707WBP
CSB-EP017707WBP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Wolbachia sp. subsp. Drosophila simulans GMP synthase [glutamine-hydrolyzing] (guaA), partial CSB-YP009582WBP
CSB-EP009582WBP
CSB-BP009582WBP
CSB-MP009582WBP
CSB-EP009582WBP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella melitensis biotype 2 Phosphatidylserine decarboxylase proenzyme (psd) CSB-YP018033BWT
CSB-EP018033BWT
CSB-BP018033BWT
CSB-MP018033BWT
CSB-EP018033BWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>